Tysabri 150 mg/ml, Injektionslösung in einer Fertigspritze
7680680080016
CH-68008
Injektionslösung
Associated product:
TYSABRI sol inj 150 mg/ml ser pré 2 x 1 ml
1 / 3
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1700.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2022
Authorization holder
Biogen Switzerland AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68008
- Drug name
- Tysabri, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AA23
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 04/11/2021
- Authorization expiration date
- 03/11/2026
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TYSABRI sol inj 150 mg/ml ser pré 2 x 1 ml
- Description (DE)
- TYSABRI Inj Lös 150 mg/ml Fertspr 2 x 1 ml
- Market launch
- 04/11/2021
- Narcotic (BTM)
- No